ENTRY       D07436                      Drug
NAME        Afelimomab (INN)
CLASS       Anti-inflammatory
             DG01985  Disease modifying anti-rheumatic drug (DMARD)
              DG01936  TNF inhibitor
REMARK      ATC code: L04AB03
EFFICACY    Immunosuppressant, Anti-TNF-alpha antibody
  TYPE      Monoclonal antibody
TARGET      TNF (TNFA, TNFSF2) [HSA:7124] [KO:K03156]
  PATHWAY   hsa04010(7124)  MAPK signaling pathway
            hsa04060(7124)  Cytokine-cytokine receptor interaction
            hsa04210(7124)  Apoptosis
            hsa04350(7124)  TGF-beta signaling pathway
            hsa04612(7124)  Antigen processing and presentation
            hsa04920(7124)  Adipocytokine signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
                 L04AB03 Afelimomab
                  D07436  Afelimomab (INN)
            Drug groups [BR:br08330]
             Anti-inflammatory
              DG01985  Disease modifying anti-rheumatic drug (DMARD)
               DG01936  TNF inhibitor
                D07436  Afelimomab
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNF (TNFA, TNFSF2)
                 D07436  Afelimomab (INN)
DBLINKS     CAS: 156227-98-4
            PubChem: 51091768
///
